Business Description
Soleno Therapeutics Inc
NAICS : 541713
SIC : 2834
ISIN : US8342032005
Description
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 84.77 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 32.3 | |||||
| 3-Year EPS without NRI Growth Rate | 34 | |||||
| 3-Year FCF Growth Rate | 37 | |||||
| 3-Year Book Growth Rate | -16.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.06 | |||||
| 9-Day RSI | 26.64 | |||||
| 14-Day RSI | 31.59 | |||||
| 6-1 Month Momentum % | 40.41 | |||||
| 12-1 Month Momentum % | 52.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.26 | |||||
| Quick Ratio | 17.26 | |||||
| Cash Ratio | 17.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -81.4 | |||||
| Shareholder Yield % | -6.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -75.42 | |||||
| ROA % | -64.68 | |||||
| ROIC % | -452.37 | |||||
| ROC (Joel Greenblatt) % | -14581.82 | |||||
| ROCE % | -73.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.97 | |||||
| Price-to-Tangible-Book | 7.17 | |||||
| EV-to-EBIT | -12.25 | |||||
| EV-to-Forward-EBIT | -17.01 | |||||
| EV-to-EBITDA | -12.43 | |||||
| EV-to-Forward-Revenue | 52.49 | |||||
| EV-to-FCF | -32.85 | |||||
| Price-to-Net-Current-Asset-Value | 8.13 | |||||
| Price-to-Net-Cash | 8.18 | |||||
| Earnings Yield (Greenblatt) % | -8.16 | |||||
| FCF Yield % | -2.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLNO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Soleno Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.347 | ||
| Beta | -3.35 | ||
| Volatility % | 43.8 | ||
| 14-Day RSI | 31.59 | ||
| 14-Day ATR ($) | 2.427576 | ||
| 20-Day SMA ($) | 49.31925 | ||
| 12-1 Month Momentum % | 52.49 | ||
| 52-Week Range ($) | 35.7 - 60.92 | ||
| Shares Outstanding (Mil) | 43.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Soleno Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Soleno Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Soleno Therapeutics Inc Frequently Asked Questions
What is Soleno Therapeutics Inc(SLNO)'s stock price today?
The current price of SLNO is $44.60. The 52 week high of SLNO is $60.92 and 52 week low is $35.70.
When is next earnings date of Soleno Therapeutics Inc(SLNO)?
The next earnings date of Soleno Therapeutics Inc(SLNO) is 2025-02-06 Est..
Does Soleno Therapeutics Inc(SLNO) pay dividends? If so, how much?
Soleno Therapeutics Inc(SLNO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers